Press Releases for JNJ

Press Releases
LMP Capital and Income Fund Inc. as of September 30, 2009
Synovis Life Technologies Reports 18 Percent Revenue Growth for Fiscal 2009 Fourth Quarter
High-tech wheelchair problem for Disney
Ektron to Assist Customers in Defining Successful Social Networking and Web Content Management Strategies
Ektron to Assist Customers in Defining Successful Social Networking and Web Content Management Strategies
Depomed Promotes William Callahan to Vice President of Operations
Let the Clean Economy Begin: Join Coca-Cola, J&J, IBM, Nokia, and Other Climate Savers Companies for Pre-Copenhagen Webinar, Wednesday, November 18
Trading Outlook for BioElectronics Corporation Issued by StockPreacher.com
LecTec Corporation and Endo Pharmaceuticals Inc. Settle Patent Dispute
CombiMatrix Corporation Reports Third Quarter 2009 Financial Results
DJO Incorporated Announces Financial Results for Third Quarter 2009
H1N1 likely behind rising hand gel sales
Q-Cells Selects Camstar for New Malaysian Mega-Factory and Upgrade of German Production Lines
Flux Power to Provide Life Extending Lithium Technology to High Power Energy Storage Market
AngioDynamics Reports Fiscal First Quarter 2010 Financial Results
2009 BlogWorld New Media Expo to Explore Social Media's Role in the Future of News
Orion Energy Systems Named Finalist for Esteemed Platts Global Energy Awards; Power Technology Company Named Finalist for Energy Efficiency Program of the Year After Winning in the Sustainable Technology Category Last Year
Best Practices to Speed-Up Pharmaceutical Analysis Processes From Johnson & Johnson, Pfizer, Genentech and Eli Lilly at Pharma IQ's Forum on Laboratory Informatics
CommScope Appoints New Principal Accounting Officer
Pappas Ventures Names Eric Linsley Managing Partner
New psoriasis drug approved
Sonoco Selected to Join the Dow Jones Sustainability World Index
Symyx Joins SAFE-BioPharma to Ensure Safe Security Standards for ELN Software; Pharmaceutical Industry Non-Profit Maintains Standards and Certification for Digital Signatures
POZEN Names Elizabeth A. Cermak As Executive Vice President, Chief Commercial Officer
Natus Medical to Acquire Alpine Biomed
Millstone Medical Outsourcing Enhances Company Leadership With Two New Hires
Celldex Therapeutics Announces Appointment of Larry Ellberger As Chairman of the Board
Are Parents a Barrier to Contact Lens Wear by Children?
FDA Issues Complete Response Letter for Carisbamate
AtTask Named an Industry Leader in SaaS/On-Demand Project Portfolio Management Solutions By Leading Analyst Firm
Morning Watch for Wednesday: Sunwin International Neutraceuticals - August 19, 2009
Palomar Successful in U.S. Patent Office Re-Examination of Second Hair Removal Patent ; Palomar to Re-Start Patent Infringement Lawsuits Against Candela and Syneron
F4SS (Foundation for Strategic Sourcing) Aims to Improve Upstream Supply Chain in the Consumer Packaged Goods (CPG) Industry ; Newly Formed Collaborative, Non-Profit Membership Organization is Focused on Driving Redundant Costs Out of the System to Improve Effectiveness and Enhance the Supply Chain in the CPG Industry
PharmaTelevision Launches the First Daily News Show for the Life Sciences Industry
Cornerstone Total Return Fund, Inc. Announces Earnings for the Quarter and Six Months Ended June 30, 2009
Chindex International Announces Exclusive Distribution Agreements in China for Leading Clinical Chemistry and Aesthetic Laser Products ; New Product Agreements Complement and Further Enhance Medical Product Offering
BioMed Realty Trust Commemorates Five-Year Anniversary As a Public Company ; Ringing NYSE Closing Bell(R) Today; Provides Tenant Update
StockPreacher.com issues Trading Outlook for Spectrum Pharmaceuticals Inc.
Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
StockPreacher.com Issues Trading Outlook for Hard to Treat Diseases Inc.
U.S. FDA approves anti-psychotic drug
Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
Compugen Reports Second Quarter 2009 Results
Community First Bank Announces Regulatory Approval of New Directors
InvestorSoup.com Issues Trading Outlook for Johnson & Johnson
Schering-Plough Reports Financial Results for 2009 Second Quarter ; Diversification Strategy and Strong Execution Continue to Drive Solid Performance;; Robust Pipeline Continues To Advance and Build Long-Term Value
Schering-Plough Reports Financial Results for 2009 Second Quarter
Autonomy Corporation Plc Announces Results for the Second Quarter and Six Months Ended June 30, 2009 ; Record Quarterly and Half Year Results With Strong Organic Growth; Highest Revenues and Profits in Autonomy's History; Q2 Revenues Up 55%; Q2 Profit Before Tax (Adjusted)* Up 76% to $89.6 Million; EPS (Diluted and Undiluted) Ahead of Expectations
Water Street Healthcare Partners Acquires Pharmaceutical Development Business From AAIPharma Inc.
Water Street Healthcare Partners Acquires Pharmaceutical Development Business From AAIPharma Inc. ; Private Equity Firm to Separate and Build AAI Division into Leading Provider of Pharmaceutical Development Services
PharmaTelevision Launches New Premium Content Service
Johnson & Johnson Reports 2009 Second-Quarter Results:
UPI NewsTrack Business
UPI NewsTrack Business
Buckman Uses AtTask to Align Corporate Vision and Objectives With Project Selection and Execution Enterprise-Wide
/C O R R E C T I O N -- Johnson & Johnson/
Johnson & Johnson Completes Acquisition of Cougar Biotechnology
DemandTec and Cannondale Associates Featured at TPMA Conference July 21, 2009 in San Francisco ; Presentation to Highlight Retailer Insights on Trade Promotion Effectiveness
Johnson & Johnson to Host Analyst Conference Call on Second-Quarter Results
Johnson & Johnson Completes Initial Tender Offer for Cougar Biotechnology
Johnson & Johnson and Elan Corporation plc Announce Definitive Agreement for Alzheimer's Immunotherapy Program and Equity Investment
UPI NewsTrack Business
Abbott ordered to pay $1.7B patent claim
Wyeth Pharmaceuticals and Catalyst Biosciences Announce Agreement to Develop and Commercialize Factor VIIa Products
Compugen Reports Sale of a Portion of Its Evogene Holdings
Centocor Ortho Biotech Inc. Awarded $1.67 Billion Patent Jury Verdict from Abbott Laboratories
New Study of Online Behavior Focuses on User Intent: Underscores Need for New Approaches in Digital Communication
wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies
UPI NewsTrack Quirks in the News
Group touts 'Take Your Dog to Work Day'
Evergreen Energy Appoints Richard Perl to the Board of Directors
wRatings and UTEK Corporation's Strategos Identify Most Competitive Health Care Companies
Girls' Overall Self-Worth Improves With Contact Lens Wear, Study Shows
Video: Get Swimsuit Ready Faster and Easier Than Ever Before With New LifeSculpt Laser Treatment
Cougar Biotechnology Announces Dismissal of Class Action Complaint Seeking to Enjoin Tender Offer and Termination of Hart-Scott-Rodino Waiting Period
CORRECTING and REPLACING New Survey: Fewer Than Half of Americans Would Give Up iPod If They Thought It Harmed the Environment; Even Fewer Would Give Up TV or Computer
SAFE-BioPharma Changes Fees to Help Clinical Investigators, CROs, Others
New Survey: Only One-Third of Americans Would Give Up iPod If They Thought It Harmed the Environment; Even Fewer Would Give Up TV or Computer
I-Therapeutix, Inc. Closes $15 Million Financing
S&P 500 Stock Buybacks Retreat 73% in the First Quarter; Lowest Since Second Quarter of 2003
Johnson & Johnson Announces Regulatory Clearance for Its Planned Acquisition of Cougar Biotechnology
University Health Systems of Eastern Carolina New Site Powered By Ektron CMS400.NET
Compugen Transfers to The NASDAQ Capital Market
June 23 DIA Sessions Chaired By SAFE-BioPharma Association
Biosense Webster to Support Landmark Clinical Trial of Atrial Fibrillation
New Analysis Shows Efficacy of SIMPONI(TM) (golimumab) in Anti-TNF Experienced Rheumatoid Arthritis Patients
Two-Year Data Show Patients Receiving SIMPONI(TM) (golimumab) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
Polymer Group, Inc. Announces Plant Consolidation and Closure
PNC Financial Services Group Names Deutsch As Advertising Agency Of Record
CORRECTING and REPLACING Cougar Biotechnology’s Board of Directors Recommends Stockholders Accept Johnson & Johnson’s $43.00 Per Share Cash Tender Offer
Cougar Biotechnology’s Board of Directors Recommends Stockholders Accept Johnson & Johnson’s $43.00 Per Share Cash Tender Offer
Johnson & Johnson Begins Tender Offer to Acquire Cougar Biotechnology
LifeTech Capital Group Joins Jesup & Lamont
Johnson & Johnson Highlights Pharmaceutical Growth Strategies and Robust Pipeline to Address Unmet Medical Needs
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
Compugen Appoints Dr. Anat Cohen-Dayag and Martin Gerstel As Co-CEOs
Biotech Shows Glimmer of an Upward Trend
Eye Related Symptoms Bring More Than Tears to Allergy Sufferers, New Survey Reveals
Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
Johnson & Johnson to Host Pharmaceutical Business Review